EUVIMEDEUVIMED entdecken
Crossref

Surgical Treatment in Very Advanced (T4b) Adenoid Cystic Carcinoma of the Head and Neck

Michael R Papazian iD, Michael Chow, Jamie Oliver, Alex J Gordon, Adam Jacobson, Alec Vaezi, Moses Tam, Babak Givi

Otolaryngology–Head and Neck Surgery · 2023

DOI: 10.1002/ohn.203 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, 2023. Verfasst von Michael R Papazian und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, NYU Langone Health, New York, New York, USA. Hauptthemen laut MEDLINE: Carcinoma, Adenoid Cystic, Mouth Neoplasms, Head and Neck Neoplasms, Carcinoma. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To compare treatment outcomes for T4b head and neck adenoid cystic carcinoma (ACC). Study Design Historical cohort study.

Setting

National Cancer Database (NCDB).

Methods

Identified all T4b ACC of head and neck origin diagnosed 2004 to 2019 in the NCDB. Demographics, clinical characteristics, treatment details, and survival were analyzed. Treatment outcomes were analyzed using univariable and multivariable Cox regression.

Results

We identified 606 cases of T4b ACC. Less than half (284, 47.0%) underwent curative‐intent treatment. Among these, most were treated with primary surgery: surgery + radiotherapy (RT) (122, 43.0%) or surgery + chemoradiotherapy (CRT) (42, 14.8%). The positive margin rate was 78.7%, and 90‐day postoperative mortality was zero. Nonsurgical patients were treated with definitive RT (60, 21.1%) or definitive CRT (60, 21.1%). The median follow‐up was 51.5 months. Overall survival was 77.8% at 3 years. Three‐year survival was higher for patients treated with surgery compared to those treated nonsurgically (84% vs 70%; p = .005). Surgical treatment remained associated with higher survival on multivariable analysis (hazard ratio [HR]: 0.47, p = .005). This effect was most pronounced for oral cavity tumors (HR: 0.17, p = .01). Among matched cohorts of surgically treated patients, there was no difference in 3‐year survival between clinical T4a and T4b tumors (83.3% vs 83.0%, p = .99).

Conclusion

Long‐term survival for T4b ACC of the head and neck could be expected. Primary surgical treatments can be performed safely and are associated with longer survival. A carefully selected subset of patients with very advanced ACC might benefit from the consideration of surgical treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Adenoid CysticMouth NeoplasmsHead and Neck NeoplasmsCarcinomaHumansCohort StudiesTreatment OutcomeRetrospective Studies

Stichwörter der Autor:innen

adenoid cystic carcinomaadvancedstage T4bsurgerysurvival

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, NYU Langone Health, New York, New York, USA.
  • Department of Otolaryngology-Head and Neck Surgery, University of Kansas Medical Center, Kansas City, New York, USA.
  • Department of Radiation Oncology, NYU Langone Health, New York, New York, USA.
  • Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

ORCID-Profile: Michael R Papazian

Zitieren

APA

Papazian, M. R., Chow, M., Oliver, J., Gordon, A. J., Jacobson, A., Vaezi, A., Tam, M., & Givi, B. (2023). Surgical Treatment in Very Advanced (T4b) Adenoid Cystic Carcinoma of the Head and Neck. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.203

Vancouver

Papazian MR, Chow M, Oliver J, Gordon AJ, Jacobson A, Vaezi A, et al. Surgical Treatment in Very Advanced (T4b) Adenoid Cystic Carcinoma of the Head and Neck. Otolaryngology–Head and Neck Surgery. 2023. doi:10.1002/ohn.203

BibTeX
@article{Papazian2023,
  author = {Papazian, Michael R and Chow, Michael and Oliver, Jamie and Gordon, Alex J and Jacobson, Adam and Vaezi, Alec and Tam, Moses and Givi, Babak},
  title = {Surgical Treatment in Very Advanced (T4b) Adenoid Cystic Carcinoma of the Head and Neck},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2023},
  doi = {10.1002/ohn.203}
}
Kostenlos starten →